Sana Biotechnology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Sana Biotechnology, Inc. (SANA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.130.130.180.250.38
Short-Term Investments0.020.070.250.300.25
Cash & Short-Term Investments0.150.210.420.550.38
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.010.000.010.010.01
Total Current Assets0.160.210.440.560.38
Non-Current Assets
Property, Plant & Equipment (Net)0.140.150.160.160.11
Long-Term Investments0.000.000.010.200.03
Goodwill0.140.140.140.140.14
Intangible Assets0.060.060.060.060.06
Other Non-Current Assets0.010.010.010.010.00
Total Non-Current Assets0.340.350.380.570.35
Total Assets0.500.570.821.130.73
Current Liabilities
Accounts Payable0.010.000.000.000.03
Short-Term Debt0.010.000.000.000.00
Accrued Liabilities0.020.040.040.010.02
Other Current Liabilities0.030.010.060.060.00
Total Current Liabilities0.050.060.110.100.03
Non-Current Liabilities
Long-Term Debt0.080.090.100.100.07
Other Non-Current Liabilities0.120.120.120.200.20
Total Non-Current Liabilities0.210.210.210.301.12
Total Liabilities0.250.280.320.401.15
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-1.60-1.34-1.05-0.79-0.43
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital1.861.631.561.520.01
Shares Outstanding0.220.200.190.180.00
Total Stockholders' Equity0.250.290.500.73-0.42
Total Liabilities & Equity0.500.570.821.130.73